Document is current

Any future updates will be listed below

Correction to: Co-pathology may impact outcomes of amyloid-targeting treatments: clinicopathological results from two patients treated with aducanumab

Crossref DOI link: https://doi.org/10.1007/s00401-025-02855-w

Published Online: 2025-02-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark